Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine.
Vaccines (Basel). 2022 Jul 21;10(7):1162. doi: 10.3390/vaccines10071162.
Vaccines (Basel). 2022.
PMID: 35891328
Free PMC article.
Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis.
Caocci G, Mulas O, Mantovani D, Costa A, Galizia A, Barabino L, Greco M, Murru R, La Nasa G.
Caocci G, et al. Among authors: barabino l.
Ann Hematol. 2022 Apr;101(4):929-931. doi: 10.1007/s00277-021-04613-w. Epub 2021 Jul 24.
Ann Hematol. 2022.
PMID: 34302519
Free PMC article.
No abstract available.
Item in Clipboard
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis.
Murru R, Galitzia A, Barabino L, Presicci R, La Nasa G, Caocci G.
Murru R, et al. Among authors: barabino l.
Ann Hematol. 2024 May;103(5):1655-1664. doi: 10.1007/s00277-024-05625-y. Epub 2024 Jan 18.
Ann Hematol. 2024.
PMID: 38236391
Free PMC article.
Item in Clipboard
Three is better than two: humoral response in allogeneic HSCT after the third BNT162b2 SARS-CoV-2 mRNA vaccine.
Barabino L, Galitzia A, Murru R, Caocci G, Greco M, Targhetta C, Angioni G, Vacca A, Piras E, Frau V, Mulas O, La Nasa G.
Barabino L, et al.
Eur Rev Med Pharmacol Sci. 2023 Aug;27(15):6914-6916. doi: 10.26355/eurrev_202308_33262.
Eur Rev Med Pharmacol Sci. 2023.
PMID: 37606101
Free article.
No abstract available.
Item in Clipboard
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study.
Mauro FR, Giannarelli D, Galluzzo CM, Visentin A, Frustaci AM, Sportoletti P, Vitale C, Reda G, Gentile M, Levato L, Murru R, Armiento D, Molinari MC, Proietti G, Pepe S, De Falco F, Mattiello V, Barabino L, Amici R, Coscia M, Tedeschi A, Girmenia C, Trentin L, Baroncelli S.
Mauro FR, et al. Among authors: barabino l.
Cancers (Basel). 2023 May 30;15(11):2993. doi: 10.3390/cancers15112993.
Cancers (Basel). 2023.
PMID: 37296954
Free PMC article.
Item in Clipboard
Clinical course and features of persistent polyclonal B-cell lymphocytosis with BCL-6 amplification during pregnancy.
Galitzia A, Murru R, Caocci G, Barabino L, Azzena A, Licheri VM, Greco M, La Nasa G.
Galitzia A, et al. Among authors: barabino l.
Eur Rev Med Pharmacol Sci. 2023 Apr;27(8):3514-3518. doi: 10.26355/eurrev_202304_32124.
Eur Rev Med Pharmacol Sci. 2023.
PMID: 37140301
Free article.
Item in Clipboard
Chronic graft vs. host disease and hypogammaglobulinemia predict a lower immunological response to the BNT162b2 mRNA COVID-19 vaccine after allogeneic hematopoietic stem cell transplantation.
Barabino L, Galitzia A, Murru R, Caocci G, Targhetta C, Greco M, Angioni G, Mulas O, Vacca A, Piras E, Frau V, Costa A, La Nasa G.
Barabino L, et al.
Eur Rev Med Pharmacol Sci. 2022 Dec;26(23):8984-8989. doi: 10.26355/eurrev_202212_30572.
Eur Rev Med Pharmacol Sci. 2022.
PMID: 36524517
Free article.
Item in Clipboard
Cite
Cite